Send to

Choose Destination
Haematologica. 2019 Aug;104(8):e345-e348. doi: 10.3324/haematol.2018.205302. Epub 2019 Feb 21.

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies.

Author information

Department of Pathology and Immunology.
Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center